Back to 
Sculptor Capital LP
Sculptor Capital LP
QNCX
Showing 0 of 3 quarters
Position history for Sculptor Capital LP's holdings in QUINCE THERAPEUTICS INC
No. Sculptor Capital exited its QNCX (Quince Therapeutics) position in Q2 2022. Its Q1 2022 13F listed 223,800 shares worth $1.4M. Sculptor Capital first reported QNCX in Q4 2021 and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.